Cargando…

From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia

BACKGROUND AND OBJECTIVES: Early diagnosis and treatment is associated with improved outcomes in patients with systemic lupus erythematosus (SLE). Studying the journey of SLE patients in Saudi Arabia is essential to direct future health-care plans. PATIENTS AND METHODS: This is a cross-sectional, mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Karremah, Mishal F, Hassan, Rola Y, Faloudah, Ammar Z, Alharbi, Lujain K, Shodari, Albraa F, Rahbeeni, Ahmad A, Alharazi, Nouf K, Binjabi, Ahmad Z, Cheikh, Mohamed M, Manasfi, Hanadi, Abdulaziz, Sultana, Hussein, Albadr Hamza, Alhazmi, Ahmed, Almoallim, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250784/
https://www.ncbi.nlm.nih.gov/pubmed/35791408
http://dx.doi.org/10.2147/OARRR.S362833
_version_ 1784739877072404480
author Karremah, Mishal F
Hassan, Rola Y
Faloudah, Ammar Z
Alharbi, Lujain K
Shodari, Albraa F
Rahbeeni, Ahmad A
Alharazi, Nouf K
Binjabi, Ahmad Z
Cheikh, Mohamed M
Manasfi, Hanadi
Abdulaziz, Sultana
Hussein, Albadr Hamza
Alhazmi, Ahmed
Almoallim, Hani
author_facet Karremah, Mishal F
Hassan, Rola Y
Faloudah, Ammar Z
Alharbi, Lujain K
Shodari, Albraa F
Rahbeeni, Ahmad A
Alharazi, Nouf K
Binjabi, Ahmad Z
Cheikh, Mohamed M
Manasfi, Hanadi
Abdulaziz, Sultana
Hussein, Albadr Hamza
Alhazmi, Ahmed
Almoallim, Hani
author_sort Karremah, Mishal F
collection PubMed
description BACKGROUND AND OBJECTIVES: Early diagnosis and treatment is associated with improved outcomes in patients with systemic lupus erythematosus (SLE). Studying the journey of SLE patients in Saudi Arabia is essential to direct future health-care plans. PATIENTS AND METHODS: This is a cross-sectional, multicenter study. Eligibility criteria included a diagnosis of SLE that was confirmed by a rheumatologist. Patients younger than 18 at the time of interview were excluded. Primary objectives were to determine time from first symptoms to initial physician visit (Lag 1), time from initial physician visit to encounter with rheumatologist (Lag 2), time from first visit to a rheumatologist to diagnosis of SLE (Lag 3), and time from diagnosis to start of treatment (Lag 4). Secondary objectives were to determine the number and specialty of physicians seen by patients, the speciality type that confirmed the diagnosis, first symptoms experienced, and age at first diagnosis of SLE. RESULTS: Three hundred patients (92.3% women) with SLE were evaluated. Mean age at diagnosis was 29.92 years. Mean disease duration was 8.1 years. The majority were college educated (43.0%). The most common initial symptom was joint pain (68%), followed by skin rash (23%), and fever (3.7%). Lag 1 was less than one month in 68.2% of patients. Lag 2 was less than one month in 33.4% of patients and exceeded one year in 25.8%. Lag 3 was less than 1 month in 68.7% of patients. Lag 4 was less than one month in 94.4% of patients. The diagnosis of SLE was made most frequently by rheumatologists (80%). Evaluation by primary care, orthopedic and dermatology physicians were associated with delays in diagnosis. CONCLUSION: Delay was marked in Lag 2. Causes of delay included evaluation by non-specialists and visiting higher numbers of physicians before diagnosis confirmation.
format Online
Article
Text
id pubmed-9250784
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92507842022-07-04 From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia Karremah, Mishal F Hassan, Rola Y Faloudah, Ammar Z Alharbi, Lujain K Shodari, Albraa F Rahbeeni, Ahmad A Alharazi, Nouf K Binjabi, Ahmad Z Cheikh, Mohamed M Manasfi, Hanadi Abdulaziz, Sultana Hussein, Albadr Hamza Alhazmi, Ahmed Almoallim, Hani Open Access Rheumatol Original Research BACKGROUND AND OBJECTIVES: Early diagnosis and treatment is associated with improved outcomes in patients with systemic lupus erythematosus (SLE). Studying the journey of SLE patients in Saudi Arabia is essential to direct future health-care plans. PATIENTS AND METHODS: This is a cross-sectional, multicenter study. Eligibility criteria included a diagnosis of SLE that was confirmed by a rheumatologist. Patients younger than 18 at the time of interview were excluded. Primary objectives were to determine time from first symptoms to initial physician visit (Lag 1), time from initial physician visit to encounter with rheumatologist (Lag 2), time from first visit to a rheumatologist to diagnosis of SLE (Lag 3), and time from diagnosis to start of treatment (Lag 4). Secondary objectives were to determine the number and specialty of physicians seen by patients, the speciality type that confirmed the diagnosis, first symptoms experienced, and age at first diagnosis of SLE. RESULTS: Three hundred patients (92.3% women) with SLE were evaluated. Mean age at diagnosis was 29.92 years. Mean disease duration was 8.1 years. The majority were college educated (43.0%). The most common initial symptom was joint pain (68%), followed by skin rash (23%), and fever (3.7%). Lag 1 was less than one month in 68.2% of patients. Lag 2 was less than one month in 33.4% of patients and exceeded one year in 25.8%. Lag 3 was less than 1 month in 68.7% of patients. Lag 4 was less than one month in 94.4% of patients. The diagnosis of SLE was made most frequently by rheumatologists (80%). Evaluation by primary care, orthopedic and dermatology physicians were associated with delays in diagnosis. CONCLUSION: Delay was marked in Lag 2. Causes of delay included evaluation by non-specialists and visiting higher numbers of physicians before diagnosis confirmation. Dove 2022-06-29 /pmc/articles/PMC9250784/ /pubmed/35791408 http://dx.doi.org/10.2147/OARRR.S362833 Text en © 2022 Karremah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Karremah, Mishal F
Hassan, Rola Y
Faloudah, Ammar Z
Alharbi, Lujain K
Shodari, Albraa F
Rahbeeni, Ahmad A
Alharazi, Nouf K
Binjabi, Ahmad Z
Cheikh, Mohamed M
Manasfi, Hanadi
Abdulaziz, Sultana
Hussein, Albadr Hamza
Alhazmi, Ahmed
Almoallim, Hani
From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
title From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
title_full From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
title_fullStr From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
title_full_unstemmed From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
title_short From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
title_sort from symptoms to diagnosis: an observational study of the journey of sle patients in saudi arabia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250784/
https://www.ncbi.nlm.nih.gov/pubmed/35791408
http://dx.doi.org/10.2147/OARRR.S362833
work_keys_str_mv AT karremahmishalf fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT hassanrolay fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT faloudahammarz fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT alharbilujaink fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT shodarialbraaf fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT rahbeeniahmada fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT alharazinoufk fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT binjabiahmadz fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT cheikhmohamedm fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT manasfihanadi fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT abdulazizsultana fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT husseinalbadrhamza fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT alhazmiahmed fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia
AT almoallimhani fromsymptomstodiagnosisanobservationalstudyofthejourneyofslepatientsinsaudiarabia